Business ❯ Corporate Governance ❯ Public Companies

Securities Regulation

SEC Filings Investor Relations Investor Protection ImmunityBio, Inc. Digital Assets Disclosure Obligations U.S. Securities and Exchange Commission Investor Compensation Market Offerings Prospectus Requirements

Keel Infrastructure Prices $400 Million Convertible to Fund AI Data‑Center Pivot

The company said proceeds will fund capped calls to curb dilution along with deposits and letters of credit for data‑center buildouts.

Multiple Plaintiff Firms Press Investors to Lead FS KKR Capital Securities Lawsuit

Lufax Investors Urged to Seek Lead Role in Securities Suit Before May 20 Deadline

ImmunityBio Faces Investor Suits After FDA Rebuke as Anktiva Sales Jump

Enphase Investors Face April 20 Deadline to Seek Lead Role in Securities Lawsuit

Securities Class Action Filed Against ImmunityBio After FDA Flags Anktiva Marketing

Aptera Closes $9 Million Public Offering of Stock and Warrants

EquipmentShare Soars 33% in Nasdaq Debut After $747 Million IPO

SharpLink Partners With Superstate to Tokenize SEC-Registered SBET Stock on Ethereum

Red Cat Prices $150 Million Stock Offering at $9.60 as Closing Nears